[Meningitis due to Listeria monocytogenes during adalimumab therapy].
Gil
Cecilia
C
Legido
Jesús
J
Cuenca
Carlos
C
Santamaría
Ana
A
Sacristán
María Victoria
MV
Salvatierra
Concepción
C
Fernández-Rubio
Eugenio
E
Izquierdo
Julio
J
D000068879:Adalimumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D008297:Male; D008584:Meningitis, Listeria / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D055815:Young Adult
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab